{"name": "Gloucester Pharmaceuticals",
 "permalink": "gloucester-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/gloucester-pharmaceuticals",
 "homepage_url": "http://www.gloucesterpharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@gloucesterpharma.com",
 "phone_number": "617-583-1300",
 "description": "",
 "created_at": "Sat Oct 10 13:03:09 UTC 2009",
 "updated_at": "Fri Aug 12 18:21:53 UTC 2011",
 "overview": "\u003Cp\u003EGloucester Pharmaceuticals is a biopharmaceutical company owned by \u003Ca href=\"/company/celgene\" title=\"Celgene\" rel=\"nofollow\"\u003ECelgene\u003C/a\u003E that acquires clinical-stage oncology drug candidates with the goal of advancing them through regulatory approval and commercialization. Gloucester\u0026#8217;s first compound, romidepsin, is a late-stage oncology drug candidate that has shown potential activity across a range of hematological malignancies. The Company retains worldwide exclusive rights to romidepsin, an oncology candidate within a new class of anti-cancer agents known as histone deacetylase (HDAC) inhibitors. Preclinical studies suggest that romidepsin is a potent inhibitor of Class I, Class II and Class IV HDACs.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       73],
      "assets/images/resized/0006/2317/62317v1-max-150x150.jpg"],
     [[236,
       115],
      "assets/images/resized/0006/2317/62317v1-max-250x250.jpg"],
     [[236,
       115],
      "assets/images/resized/0006/2317/62317v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Director",
    "person":
     {"first_name": "David",
      "last_name": "Schnell",
      "permalink": "david-schnell",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$29M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://www.gloucesterpharma.com/press/releases/pr082509.html",
    "source_description": "Gloucester Pharmaceuticals Completes $29 Million Financing",
    "raised_amount": 29000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 8,
    "funded_day": 25,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novo Ventures",
         "permalink": "novo-ventures",
         "image":
          {"available_sizes":
            [[[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-150x150.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-250x250.jpg"],
             [[133,
               56],
              "assets/images/resized/0004/6080/46080v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Apple Tree Partners",
         "permalink": "apple-tree-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/8810/48810v2-max-150x150.png"],
             [[250,
               35],
              "assets/images/resized/0004/8810/48810v2-max-250x250.png"],
             [[318,
               45],
              "assets/images/resized/0004/8810/48810v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ProQuest Investments",
         "permalink": "proquest-investments",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/2876/52876v1-max-150x150.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-250x250.jpg"],
             [[236,
               79],
              "assets/images/resized/0005/2876/52876v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Prospect Venture Partners",
         "permalink": "prospect-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               81],
              "assets/images/resized/0003/4207/34207v1-max-150x150.png"],
             [[195,
               106],
              "assets/images/resized/0003/4207/34207v1-max-250x250.png"],
             [[195,
               106],
              "assets/images/resized/0003/4207/34207v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rho Capital Partners",
         "permalink": "rho-capital-ventures",
         "image":
          {"available_sizes":
            [[[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-150x150.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-250x250.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 640000000.0,
   "price_currency_code": "USD",
   "term_code": "cash_and_stock",
   "source_url": "http://www.masshightech.com/stories/2009/12/07/daily1-Gloucester-Pharma-selling-for-640M-to-Celgene.html",
   "source_description": "Gloucester Pharma selling for $640M to Celgene",
   "acquired_year": 2009,
   "acquired_month": 12,
   "acquired_day": 7,
   "acquiring_company":
    {"name": "Celgene",
     "permalink": "celgene",
     "image":
      {"available_sizes":
        [[[113,
           99],
          "assets/images/resized/0006/8834/68834v1-max-150x150.png"],
         [[113,
           99],
          "assets/images/resized/0006/8834/68834v1-max-250x250.png"],
         [[113,
           99],
          "assets/images/resized/0006/8834/68834v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "One Broadway, 14th Floor",
    "address2": "",
    "zip_code": "02142",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        110],
       "assets/images/resized/0006/2318/62318v1-max-150x150.jpg"],
      [[250,
        183],
       "assets/images/resized/0006/2318/62318v1-max-250x250.jpg"],
      [[450,
        330],
       "assets/images/resized/0006/2318/62318v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}